Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mirum Pharmaceuticals, Inc.(MIRM) | 6,495,392 | 6,570,392 | +75,000 | $222.08M | $256.25M | 10.27% | +$34.17M |
| Newamsterdam Pharma Company ORDINARY SHARES | 12,226,943 | 12,855,194 | +628,251 | $234.88M | $213.40M | 8.55% | -$21.48M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 10,109,279 | 10,109,279 | 0 | $104.13M | $182.78M | 7.33% | +$78.65M |
| Krystal Biotech, Inc.(KRYS) | 988,460 | 988,460 | 0 | $181.52M | $179.93M | 7.21% | -$1.59M |
| MBX Biosciences, Inc.(MBX) | 0 | 5,985,347 | +5,985,347 | $0 | $155.50M | 6.23% | +$155.50M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,371,304 | 2,416,952 | +45,648 | $97.37M | $126.62M | 5.08% | +$29.26M |
| Vaxcyte, Inc.(PCVX) | 1,039,405 | 879,405 | -160,000 | $78.49M | $100.49M | 4.03% | +$22.00M |
| Verona Pharma PlcADS | 3,314,349 | 3,383,950 | +69,601 | $47.93M | $97.36M | 3.90% | +$49.43M |
| BridgeBio Pharma, Inc.(BBIO) | 3,632,604 | 3,760,457 | +127,853 | $92.01M | $95.74M | 3.84% | +$3.73M |
| Disc Medicine, Inc.(IRON) | 1,754,834 | 1,754,834 | 0 | $79.09M | $86.23M | 3.46% | +$7.14M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 8,785,284 | 8,785,284 | 0 | $81.70M | $81.70M | 3.27% | $0 |
| Edgewise Therapeutics, Inc.(EWTX) | 3,731,067 | 2,832,867 | -898,200 | $67.20M | $75.61M | 3.03% | +$8.41M |
| Anaptysbio Inc | 2,165,591 | 2,209,189 | +43,598 | $54.27M | $74.01M | 2.97% | +$19.74M |
| Erasca, Inc.(ERAS) | 16,216,216 | 19,391,687 | +3,175,471 | $38.27M | $52.94M | 2.12% | +$14.67M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,587,527 | 1,587,527 | 0 | $43.15M | $52.21M | 2.09% | +$9.06M |
| Agios Pharmaceuticals, Inc.(AGIO) | 871,974 | 1,044,154 | +172,180 | $37.60M | $46.39M | 1.86% | +$8.79M |
| Revolution Medicines, Inc.(RVMD) | 997,455 | 997,455 | 0 | $38.71M | $45.23M | 1.81% | +$6.52M |
| Soleno Therapeutics Inc | 875,667 | 875,667 | 0 | $35.73M | $44.21M | 1.77% | +$8.49M |
| Kalvista Pharmaceuticals Inc | 3,687,867 | 3,687,867 | 0 | $43.44M | $42.71M | 1.71% | -$737.6K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,142,855 | 4,142,855 | 0 | $29.29M | $42.46M | 1.70% | +$13.17M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 425,000 | 633,715 | +208,715 | $17.47M | $35.20M | 1.41% | +$17.74M |
| Savara Inc.(SVRA) | 8,157,385 | 8,157,385 | 0 | $32.87M | $34.59M | 1.39% | +$1.71M |
| CG Oncology, Inc.(CGON) | 770,000 | 770,000 | 0 | $24.31M | $29.05M | 1.16% | +$4.74M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,561,230 | 1,485,630 | -75,600 | $33.61M | $27.44M | 1.10% | -$6.17M |
| Trevi Therapeutics, Inc.(TRVI) | 7,381,090 | 7,381,090 | 0 | $22.00M | $24.65M | 0.99% | +$2.66M |
| Mereo BioPharma Group plcADS(MREO) | 4,401,371 | 5,097,779 | +696,408 | $15.84M | $20.95M | 0.84% | +$5.11M |
| Silence Therapeutics plcADS(SLN) | 1,148,591 | 1,148,591 | 0 | $21.82M | $20.88M | 0.84% | -$941.8K |
| Ascendis Pharma A/SADR(ASND) | 0 | 133,333 | +133,333 | $0 | $19.91M | 0.80% | +$19.91M |
| Hillevax Inc | 10,617,062 | 10,617,062 | 0 | $153.52M | $18.69M | 0.75% | -$134.84M |
| Merus N V | 373,100 | 373,100 | 0 | $22.08M | $18.64M | 0.75% | -$3.44M |
| Tyra Biosciences, Inc.(TYRA) | 832,220 | 731,020 | -101,200 | $13.31M | $17.19M | 0.69% | +$3.88M |
| Autolus Therapeutics plcADS(AUTL) | 4,623,324 | 4,623,324 | 0 | $16.09M | $16.78M | 0.67% | +$693.5K |
| Alkermes plcSHS(ALKS) | 0 | 576,129 | +576,129 | $0 | $16.13M | 0.65% | +$16.13M |
| Immatics N.V.SHS(IMTX) | 1,152,456 | 1,354,711 | +202,255 | $13.39M | $15.46M | 0.62% | +$2.07M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 477,327 | +477,327 | $0 | $11.70M | 0.47% | +$11.70M |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 1,250,786 | +1,250,786 | $0 | $11.31M | 0.45% | +$11.31M |
| Design Therapeutics, Inc.(DSGN) | 1,195,179 | 1,892,547 | +697,368 | $4.00M | $10.18M | 0.41% | +$6.18M |
| Cogent Biosciences, Inc.(COGT) | 936,576 | 936,576 | 0 | $7.90M | $10.12M | 0.41% | +$2.22M |
| MacroGenics, Inc.(MGNX) | 3,010,727 | 3,010,727 | 0 | $12.80M | $9.91M | 0.40% | -$2.89M |
| Day One Biopharmaceuticals I COM | 0 | 689,655 | +689,655 | $0 | $9.61M | 0.39% | +$9.61M |
| Allogene Therapeutics Inc | 2,867,750 | 2,867,750 | 0 | $6.68M | $8.03M | 0.32% | +$1.35M |
| Puma Biotechnology, Inc.(PBYI) | 3,062,558 | 3,062,558 | 0 | $9.98M | $7.81M | 0.31% | -$2.17M |
| Adverum Biotechnologies Inc | 1,069,244 | 1,069,244 | 0 | $7.34M | $7.51M | 0.30% | +$171.1K |
| 89bio Inc | 1,000,000 | 1,000,000 | 0 | $8.01M | $7.40M | 0.30% | -$610.0K |
| Acadia Pharmaceuticals Inc | 470,338 | 470,338 | 0 | $7.64M | $7.23M | 0.29% | -$409.2K |
| Arvinas, Inc.(ARVN) | 285,331 | 285,331 | 0 | $7.60M | $7.03M | 0.28% | -$567.8K |
| PepGen Inc.(PEPG) | 1,502,788 | 702,694 | -800,094 | $23.98M | $6.01M | 0.24% | -$17.98M |
| Elevation Oncology Inc | 2,958,579 | 5,993,579 | +3,035,000 | $7.99M | $3.60M | 0.14% | -$4.39M |
| Newamsterdam Pharma CompanyW EXP 11 22 202 *W EXP 99/99/999 | 500,333 | 500,333 | 0 | $4.36M | $3.50M | 0.14% | -$860.6K |
| Immunocore Holdings plcADS(IMCR) | 108,762 | 108,762 | 0 | $3.69M | $3.39M | 0.14% | -$300.2K |
| Nuvation Bio Inc.CL A(NUVB) | 0 | 1,218,236 | +1,218,236 | $0 | $2.79M | 0.11% | +$2.79M |
| Aclaris Therapeutics, Inc.(ACRS) | 264,377 | 264,377 | 0 | $290.8K | $304.0K | 0.01% | +$13.2K |
| Pieris Pharmaceuticals Inc | 0 | 15,942 | +15,942 | $0 | $266.9K | 0.01% | +$266.9K |
| An2 Therapeutics Inc | 2,088,889 | 0 | -2,088,889 | $4.49M | $0 | — | -$4.49M |
| Applied Therapeutics Inc | 2,286,135 | 0 | -2,286,135 | $10.68M | $0 | — | -$10.68M |
| Cerevel Therapeutics Hldng I | 393,000 | 0 | -393,000 | $16.07M | $0 | — | -$16.07M |
| Metagenomi Therapeutics, Inc.(MGX) | 245,692 | 0 | -245,692 | $1.00M | $0 | — | -$1.00M |